82019-50-9 Usage
Uses
Used in Pharmaceutical Research:
2,4,6-Trifluorobenzamide is used as a research compound for its potential role in the development of new drugs. Its specific properties allow it to be a valuable component in the synthesis of pharmaceuticals, contributing to the discovery of novel therapeutic agents.
Used in Agrochemical Development:
In the agrochemical industry, 2,4,6-trifluorobenzamide is utilized as a starting material or intermediate in the synthesis of various agrochemicals. Its stability and biological activity make it suitable for the creation of effective and environmentally friendly pesticides.
Used as a Building Block in Organic Synthesis:
2,4,6-Trifluorobenzamide is employed as a key building block in the synthesis of other organic compounds. Its unique structure and reactivity enable the production of a wide range of chemical entities for various applications across different industries.
Used in the Development of New Pesticides:
Due to its biological activity, 2,4,6-trifluorobenzamide may be used in the development of innovative pesticides. Its potential to target specific pests while minimizing environmental impact makes it a valuable asset in modern pest control strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 82019-50-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,0,1 and 9 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 82019-50:
(7*8)+(6*2)+(5*0)+(4*1)+(3*9)+(2*5)+(1*0)=109
109 % 10 = 9
So 82019-50-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H4F3NO/c8-3-1-4(9)6(7(11)12)5(10)2-3/h1-2H,(H2,11,12)
82019-50-9Relevant academic research and scientific papers
5HT1F RECEPTOR AGONISTS AND MITOCHONDRIAL BIOGENESIS
-
Page/Page column 15, (2018/05/24)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.
